Physician profile
Michael Link
NPI 1477617710
$95,730.37
in general payments reported to CMS, 2019-2025
37 companies · $11K in 2025
The $11K reported for 2025 was more than what 82% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $14K · 2021: $21K · 2022: $4,036 · 2023: $2,058 · 2024: $4,987 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $6,226 · Travel and Lodging: $2,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,000.00 |
| Food and Beverage | $6,225.70 |
| Travel and Lodging | $2,120.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $45,625.07 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19,637.87 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $17,869.09 | 2019-2020 | |
| Medtronic Vascular, INC. | $3,403.80 | 2019-2020 | |
| Boston Scientific Corporation | $2,548.81 | 2019-2025 | Watchman Flx, Bodyguardian, Watchman Access System |
| Abbott Laboratories | $2,237.87 | 2021-2025 | Gallant, Aveir, Jot Dx |
| Medtronic, INC. | $1,380.65 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Selectsecure |
| Impulse Dynamics (USA) INC. | $649.72 | 2023-2025 | Optimizer, Optimizer |
| Biosense Webster, INC. | $463.79 | 2021-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Biotronik INC. | $340.50 | 2022-2024 | Biomonitor |
| Philips North America LLC | $299.01 | 2019-2025 | (5044) Mcot, (5050) Extended Holter, Extended Holter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $205.90 | 2021-2025 | Lifevest |
| Pfizer INC. | $169.30 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $112.44 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $89.44 | 2022-2023 | Verquvo |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $89.32 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Perclot |
| Haemonetics Corporation | $88.52 | 2023 | Teg6s Hemostasis System |
| E.R. Squibb & Sons, L.L.C. | $55.73 | 2023 | Camzyos |
| Altathera Pharmaceuticals LLC | $55.39 | 2023-2024 | Sotalol Hydrochloride |
| Shockwave Medical, INC | $54.66 | 2022 | |
| Amarin Pharma, INC. | $44.02 | 2021 | |
| Genzyme Corporation | $38.97 | 2024-2025 | |
| Heartflow, INC. | $36.01 | 2024-2025 | |
| Terumo Medical Corporation | $27.58 | 2023 | Azur Cx Detachable, Progreat |
| Bayer Healthcare Pharmaceuticals INC. | $20.00 | 2024 | |
| Janssen Pharmaceuticals, INC | $17.95 | 2024 | Xarelto |
| Glaxosmithkline, LLC. | $16.95 | 2025 | Shingrix |
| Daiichi Sankyo INC. | $16.64 | 2023 | Injectafer |
| Scpharmaceuticals INC. | $16.62 | 2025 | |
| Sanofi-Aventis U.S. LLC | $16.51 | 2024 | |
| Irhythm Technologies, INC. | $16.07 | 2022 | |
| W. L. Gore & Associates, INC. | $16.00 | 2023 | Gore Cardioform Septal Occluder |
| Kiniksa Pharmaceuticals International, Plc | $15.98 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $15.28 | 2023 | Evkeeza |
| Novo Nordisk INC | $14.01 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $13.86 | 2021 | |
| Preventice Services, LLC | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Link listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.